Bollard Group LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bollard Group LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2020$1,121,000
+20.9%
10,0000.0%0.04%
+27.3%
Q3 2020$927,000
+18.8%
10,0000.0%0.03%
+6.5%
Q2 2020$780,000
+33.3%
10,0000.0%0.03%
+19.2%
Q1 2020$585,000
-27.0%
10,0000.0%0.03%0.0%
Q4 2019$801,000
+9.0%
10,0000.0%0.03%0.0%
Q3 2019$735,000
-80.6%
10,000
-78.9%
0.03%
-81.8%
Q1 2019$3,786,000
+48.5%
47,3000.0%0.14%
+27.7%
Q4 2018$2,550,000
-28.2%
47,300
+4.0%
0.11%
-21.7%
Q3 2018$3,552,000
+5.6%
45,500
-14.2%
0.14%
-7.7%
Q2 2018$3,364,000
-4.1%
53,000
+38.6%
0.16%
-10.9%
Q1 2018$3,508,00038,2500.17%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders